Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-06-06 09:54 am Sale |
2024-05-31 | 13G | Sage Therapeutics, Inc. SAGE |
WELLINGTON MANAGEMENT CO LLP | 39,757 0.070% |
-6,022,239 (-99.34%) |
Filing History |
| 2024-02-14 07:09 am Purchase |
2023-12-31 | 13G | Sage Therapeutics, Inc. SAGE |
RTW Investments, LP | 5,197,019 8.700% |
5,197,019 (New Position) |
Filing History |
| 2024-02-13 5:13 pm Purchase |
2023-12-29 | 13G | Sage Therapeutics, Inc. SAGE |
The Vanguard Group | 5,319,360 8.860% |
433,808 (+8.88%) |
Filing History |
| 2024-02-13 06:28 am Purchase |
2023-12-31 | 13G | Sage Therapeutics, Inc. SAGE |
BB BIOTECH AG | 3,505,000 5.800% |
404,722 (+13.05%) |
Filing History |
| 2024-02-09 09:49 am Sale |
2024-02-08 | 13G | Sage Therapeutics, Inc. SAGE |
FMR CORP | 5,482,477 9.132% |
-1,069,013 (-16.32%) |
Filing History |
| 2024-02-08 10:17 am Sale |
2023-12-29 | 13G | Sage Therapeutics, Inc. SAGE |
WELLINGTON MANAGEMENT CO LLP | 6,061,996 10.100% |
-301,634 (-4.74%) |
Filing History |
| 2024-01-26 11:49 am Sale |
2023-12-31 | 13G | Sage Therapeutics, Inc. SAGE |
BLACKROCK INC BLK |
4,663,900 7.800% |
-246,242 (-5.01%) |
Filing History |
| 2024-01-24 10:04 am Purchase |
2023-12-31 | 13G | Sage Therapeutics, Inc. SAGE |
STATE STREET CORP STT |
3,918,222 6.530% |
3,918,222 (New Position) |
Filing History |
| 2023-07-10 08:44 am Purchase |
2023-06-30 | 13G | Sage Therapeutics, Inc. SAGE |
WELLINGTON MANAGEMENT CO LLP | 6,363,630 10.650% |
847,494 (+15.36%) |
Filing History |
| 2023-02-17 5:23 pm Purchase |
2023-02-09 | 13G | Sage Therapeutics, Inc. SAGE |
BB BIOTECH AG | 3,100,278 5.200% |
150,000 (+5.08%) |
Filing History |
| 2023-02-14 4:16 pm Sale |
2022-12-31 | 13G | Sage Therapeutics, Inc. SAGE |
BB BIOTECH AG | 2,950,278 5.000% |
-219,826 (-6.93%) |
Filing History |
| 2023-02-09 12:31 pm Purchase |
2023-02-09 | 13G | Sage Therapeutics, Inc. SAGE |
FMR CORP | 6,551,490 11.012% |
574,397 (+9.61%) |
Filing History |
| 2023-02-09 11:32 am Purchase |
2022-12-30 | 13G | Sage Therapeutics, Inc. SAGE |
The Vanguard Group | 4,885,552 8.210% |
307,311 (+6.71%) |
Filing History |
| 2023-02-06 2:58 pm Sale |
2022-12-30 | 13G | Sage Therapeutics, Inc. SAGE |
WELLINGTON MANAGEMENT CO LLP | 5,516,136 9.270% |
-1,610,275 (-22.60%) |
Filing History |
| 2023-02-03 12:10 pm Purchase |
2022-12-31 | 13G | Sage Therapeutics, Inc. SAGE |
BLACKROCK INC BLK |
4,910,142 8.300% |
1,999,872 (+68.72%) |
Filing History |
| 2022-07-11 08:49 am Purchase |
2022-07-08 | 13G | Sage Therapeutics, Inc. SAGE |
FMR CORP | 5,977,093 10.119% |
486,519 (+8.86%) |
Filing History |
| 2022-02-11 4:36 pm Purchase |
2021-12-31 | 13G | Sage Therapeutics, Inc. SAGE |
BB BIOTECH AG | 3,170,104 5.400% |
210,000 (+7.09%) |
Filing History |
| 2022-02-10 08:37 am Sale |
2021-12-31 | 13G | Sage Therapeutics, Inc. SAGE |
The Vanguard Group | 4,578,241 7.770% |
-20,874 (-0.45%) |
Filing History |
| 2022-02-09 10:24 am Sale |
2022-02-08 | 13G | Sage Therapeutics, Inc. SAGE |
FMR CORP | 5,490,574 9.320% |
-188,697 (-3.32%) |
Filing History |
| 2022-02-04 09:22 am Purchase |
2021-12-31 | 13G | Sage Therapeutics, Inc. SAGE |
WELLINGTON MANAGEMENT CO LLP | 7,126,411 12.100% |
999,731 (+16.32%) |
Filing History |